Assessing the exercise response to a bronchodilator in COPD: Time to get off your bike?

Thorax

Volumn 62, Issue 4, 2007, Pages 281-283

  Morgan, M D L ^a   Singh, S J ^a  

^a GLENFIELD HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BRONCHODILATING AGENT;

AIRWAY OBSTRUCTION; BICYCLE ERGOMETRY; BRONCHODILATATION; CHRONIC OBSTRUCTIVE LUNG DISEASE; DYSPNEA; EDITORIAL; ENDURANCE; EXERCISE; FORCED EXPIRATORY VOLUME; HUMAN; OXYGEN CONSUMPTION; PATHOPHYSIOLOGY; PHYSICAL ACTIVITY; PRIORITY JOURNAL; THERMOREGULATION;

BICYCLING; BRONCHODILATOR AGENTS; EXERCISE; EXERCISE TEST; FORCED EXPIRATORY VOLUME; HUMANS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE;

EID: 34147194150     PISSN: 00406376     EISSN: None     Source Type: Journal    
DOI: 10.1136/thx.2006.069195     Document Type: Editorial

References (23)

1. Pepin V, Brodeur J, Lacasse Y, et al. Six-minute walking versus shuttle walking: responsiveness to bronchodilatation in chronic obstructive pulmonary disease. Thorax 2007;62:291-8.
2. Aliverti A, Stevenson N, Dellaca RL, et al. Regional chest wall volumes during exercise in chronic obstructive pulmonary disease. Thorax 2004;59:210-6.
3. Aliverti A, Rodger K, Dellaca RL, et al. Effect of salbutamol on lung function and chest wall volumes at rest and during exercise in COPD. Thorax 2005;60:916-24.
4. Man WD, Soliman MG, Gearing J, et al. Symptoms and quadriceps fatigability after walking and cycling in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2003;168:562-7.
5. Punzal PA, Ries AL, Kaplan RM, et al. Maximum intensity exercise training in patients with chronic obstructive pulmonary disease. Chest 1991;100:618-23.
6. Mathur RS, Revill SM, Vara DD, et al. Comparison of peak oxygen consumption during cycle and treadmill exercise in severe chronic obstructive pulmonary disease. Thorax 1995;50:829-33.
7. Killian KJ, Leblanc P, Martin DH, et al. Exercise capacity and ventilatory, circulatory, and symptom limitation in patients with chronic airflow limitation. Am Rev Respir Dis 1992;146:935-40.
8. Pepin V, Saey D, Whittom F, et al. Walking versus cycling: sensitivity to bronchodilation in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2005;172:1517-22.
9. Lacasse Y, Goldstein R, Lasserson TJ, et al. Pulmonary rehabilitation for chronic obstructive pulmonary disease. Cochrane Database Syst Rev 2006;(4):CD003793.
10. Revill SM, Morgan MD, Singh SJ, et al. The endurance shuttle walk: a new field test for the assessment of endurance capacity in chronic obstructive pulmonary disease. Thorax 1999;54:213-22.
11. Liesker JJ, Wijkstra PJ, ten Hacken NH, et al. A systematic review of the effects of bronchodilators on exercise capacity in patients with COPD. Chest 2002;121:597-608.
12. O'Donnell DE, Sciurba F, Celli B, et al. Effect of fluticasone propionate/salmeterol on lung hyperinflation and exercise endurance in COPD. Chest 2006;130:647-56.
13. O'Donnell DE, Voduc N, Fitzpatrick M, et al. Effect of salmeterol on the ventilatory response to exercise in chronic obstructive pulmonary disease. Eur Respir J 2004;24:86-94.
14. O'Donnell DE, Fluge T, Gerken F, et al. Effects of tiotropium on lung hyperinflation, dyspnoea and exercise tolerance in COPD. Eur Respir J 2004;23:832-40.
15. Oga T, Nishimura K, Tsukino M, et al. A comparison of the effects of salbutamol and ipratropium bromide on exercise endurance in patients with COPD. Chest 2003;123:1810-6.
16. van't HA, Gosselink R, Kwakkel G. Constant-load cycle endurance performance: test-retest reliability and validity in patients with COPD. J Cardiopulm Rehabil 2003;23:143-50.
17. Sewell L, Singh SJ, Williams JE, et al. Can individualized rehabilitation improve functional independence in elderly patients with COPD? Chest 2005;128:1194-200.
18. Palange P, Forte S, Onorati P, et al. Ventilatory and metabolic adaptations to walking and cycling in patients with COPD. J Appl Physiol 2000;88:1715-20.
19. Oga T, Nishimura K, Tsukino M, et al. The effects of oxitropium bromide on exercise performance in patients with stable chronic obstructive pulmonary disease. A comparison of three different exercise tests. Am J Respir Crit Care Med 2000;161:1897-901.
20. Butland RJ, Pang J, Gross ER, et al. Two-, six-, and 12-minute walking tests in respiratory disease. BMJ (Clin Res Ed) 1982;284:1607-8.
21. Singh SJ, Morgan MD, Scott S, et al. Development of a shuttle walking test of disability in patients with chronic airways obstruction. Thorax 1992;47:1019-24.
22. Onorati P, Antonucci R, Valli G, et al. Non-invasive evaluation of gas exchange during a shuttle walking test vs. a 6-min walking test to assess exercise tolerance in COPD patients. Eur J Appl Physiol 2003;89:331-6.
23. Casaburi R, Kukafka D, Cooper CB, et al. Improvement in exercise tolerance with the combination of tiotropium and pulmonary rehabilitation in patients with COPD. Chest 2005;127:809-17.